XBI Long

Zaktualizowano
Lawmakers benefit from taxes generated from biotech, and big pharma companies that are generating massive revenues. Expecting LABU ~$50-55 range by mid September.
Uwaga
This is when the highs are tested. I would expect a flat line until December. The profit margin is more of a gamble than can be rationally predicted.
biotechLABDLABUXBI

Wyłączenie odpowiedzialności